- Filed
- Nov 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 3.27M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 3.27M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 3.29M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 2.84M sh |
| Capex | Q3 2025 · Sep 30, 2025 | $119K |
| Capex | Q3 2025 · Sep 30, 2024 | $0 |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$65.51M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$52.89M |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $214.18M |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $108.91M |
| Short Term Debt | Q3 2025 · Sep 30, 2025 | $114K |
| Short Term Debt | Q3 2025 · Dec 31, 2024 | $0 |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $37.71M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $38.82M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2024 | $62.96M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | −$18.69M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $44.46M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $63.25M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $75.94M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $120.51M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $166.84M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $146.6M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $142.13M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $423.95M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $496.42M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $664.64M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $633.89M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $135.63M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $184.14M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $683.56M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $783.42M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$9.67 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$22.18 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$15.70 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$32.17 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$9.67 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$22.18 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$14.36 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$12.02 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $22.14M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $70.43M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $27.22M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $81.23M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$31.59M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$72.43M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$46.51M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$77.23M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$44.22M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$116.44M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$106.99M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$182.16M |
| Revenue | Q3 2025 · Sep 30, 2025 | $345.25M |
| Revenue | Q3 2025 · Sep 30, 2025 | $1.07B |
| Revenue | Q3 2025 · Sep 30, 2024 | $362.12M |
| Revenue | Q3 2025 · Sep 30, 2024 | $1.13B |